pharma
Loading...
Symbols:
Authors:
Loading...
Symbols:
Authors:
comments80
- Positive ratings 0
- Negative ratings 0
- Net rating 0
Or filter by symbol:
ABK
AGO
ALKS
AMLN
APA
ARIA
BAC
BBH
BMY
BRK.A
BRK.B
BSC
CELG
CFC
CSX
DBA
DBC
DBO
DCR
DGL
DIA
DJP
DNA
DNDN
DRR
DUG
EFA
ENZN
FNM
FRE
FSLR
FXE
GDX
GLD
GOOG
GSG
IAU
IEF
IEO
IEZ
IMCL
IMGN
INCY
IVV
JPM
LEH
LLY
MBI
MSFT
NVO
OIH
OIL
OSIP
QQQQ
REGN
RHHBY.PK
RSX
SGEN
SPY
TRF
UDN
USL
USO
UUP
WFC
XHB
XLE
XOP
XTO
YHOO
... [+more]
Hedge Fund Jobs
Job Seekers: Search jobs by category, get job alerts by email or live feed, apply online See full list of jobs »
Employers: See all recruitment options, get applications online or by email Post a job »
Trading Center
- Free E-Newsletters
- Wall Street Breakfast -Sample
Wall Street Breakfast: Must-Know Newsby SA Editor Rachael Granby- Bank trio becomes duo. Wells Fargo (WFC) will become the largest U.S. bank by branches with its bid for Wachovia (WB), after Citigroup (C) withdrew from compromise negotiations late yesterday on concerns about the quality of some of Wachovia's assets. Wells Fargo, with a bid valued at $11.4B, expects the purchase to be completed by the end of the year, and denies it will have to absorb assets shakier than originally thought.
- Government considers next steps. As the financial crisis continues to worsen, the U.S. government is considering two dramatic steps to turn around, or at least slow, the damage: guaranteeing billions of dollars in bank debt and temporarily insuring all U.S. bank deposits. The moves, which would mark the government's most extensive intervention to date, are in discussion stages only.
- Credit stays frozen. As frozen credit markets refuse to thaw, the cost of default protection on corporate bonds reaches new global records amid investor concerns the credit crisis will trigger corporate failures as companies struggle to finance their businesses. Interbank lending remains limited, and borrowing from the Fed's expanded discount window continued its trend of setting new highs every week, as the total daily average rose to $420.2B vs. $367.8B last week.
- Oil demand withers. The International Energy Agency warned Friday worldwide oil demand...
- The Macro View -SampleSeeking Alpha - The Macro ViewMarket Outlook
- An Outcry from Emerging and Developed Markets Alike by Jonathan O'Shaughnessy
- Long Term, Financials Look Good by Michael Filloon
- Round 3 of the Recession: Main Street by Paul Fekula
Oil Price- Oil Below $75: Increased Chance of OPEC Production Cuts by Money Morning
- Oil Down 48% from Highs by Bespoke Investment Group
- Oil & Gas Headed Lower as Economy Strikes Consumers by Michael Filloon
Economy- Long Term, Financials Look Good by Michael Filloon
- Round 3 of the Recession: Main Street by Paul Fekula
- Reality Bites As Stocks Continue To Collapse by The Mole
- Investing Ideas -SampleSeeking Alpha - Investing IdeasCramer's Picks
- Farewell Financial Bear Raids - Cramer's Mad Money (10/14/08) by SA Editor Joan Wickham
- Better Picks - Cramer's Lightning Round (10/14/08) by SA Editor Joan Wickham
- Perhaps Industrials... Cramer's Stop Trading! (10/14/08) by SA Editor Joan Wickham
Long Ideas- Utilities Beginning to Generate Interest for Longs by Joe Kunkle
- The Long Case for Encore Capital by Value Investor Insight
- 2009: The Year of the Channel for SaaS Vendors? by Jeff Kaplan
- Two Global Infrastructure Investment Opportunities in ETFs by Investment U
- Market Behaves Sanely - Fast Money Recap (10/14/08) by SA Editor Joan Wickham
Short Ideas- Why Short Sellers Are the Heroes of Wall Street by Investment U
- Salesforce.com: Pricey and Coming Down Fast by Charlie Bottle
- Google: 3Q Results Reveal Chinks in the Armor by Mark Krieger
- Jim Cramer's Picks -SampleBetter Choices - Cramer's Lightning Round (10/15/08)by SA Editor Rachael GranbyStocks discussed in the lightning round session of Jim Cramers Mad Money TV program,
Wednesday, October 15.Bullish Calls:Continental Resources (CLR) -- "This is a remarkable decline. All of the high quality ones are down so much, I can't go against it. This is where you pull the trigger.
3M (MMM) -- The moment this stock starts yielding 5%, I'm a buyer. Until then, keep your powder dry.Bearish Calls:Computer Sciences (CSC) -- This is a company that was going to be bought, but they passed up the chance. Now I don't want to buy it."Email continues...
Annaly Mortgage (NLY) -- I think this is a business model that needs to borrow money. Definitively do not buy."
Northrop Grumman (NOC) -- You can't own the defense stocks right now. If I had to own one, I'd look at Lockheed Martin (LMT) with its good dividend. - Stocks & Sectors -SampleSeeking Alpha - Stocks & SectorsInternet
- eBay: Q3 Looks Good but Q4 Guidance Disappoints by Greg Feirman
- Is Google Feeling Lucky? by Sam Gustin
- Why Today Could Suck for Tech by Kevin Maney
Media- A Triple Financial Whammy Afflicts Newspapers by Ken Doctor
- Three Years On, Buying MySpace Looks Like One of Murdoch's Smartest Bets by Erick Schonfeld
- How Will Arbitron Fare in This Market? by Sreeni Meka
Telecom- Ten Ways to Invest in Louisiana by Stockerblog
- Earnings Preview: Electro-Optical Engineering by theflyonthewall.com
- Shared Docks Via WiFi All the Rage by Dean Bubley
Financial- Switzerland Strengthens Its Banks; Short Interest Remains Low by Jessica Johnson
- Reality Bites As Stocks Continue To Collapse by The Mole
- LIBOR Shows Worst Is Yet to Come for Credit Markets by Keith Fitz-Gerald
- Global Markets -SampleSeeking Alpha - Global MarketsChina
- An Outcry from Emerging and Developed Markets Alike by Jonathan O'Shaughnessy
- USANA Health Sciences Inc. Q3 2008 Earnings Call Transcript
- Perfect World Announces Share Repurchase Program by Trader Mark
- China: Hot Money Inflows Down, Nervousness Up by Michael Pettis
India- Indian Economy Has Much to Cheer About by Equitymaster
- India: RBI Cuts Cash Reserve Ratio by Equitymaster
- India: Markets Continue Downward by Equitymaster
Japan- Sanyo Enters Thin-Film Market, Goes Up Against Sharp by Greentech Media
Asia- Four International Dividend Stocks to Watch by David Hunkar
Eastern Europe- Reality Bites As Stocks Continue To Collapse by The Mole
- Alternative Energy Investing -SampleSeeking Alpha - Alternative EnergyAlternative Energy
- Seven Stocks for an Impending Apocalypse by H.J. Huneycutt
- Solar Shares Under Pressure From Credit Crunch and Pricing by Eric Savitz
- Trina Solar Looks Good, Though Market Yawns by Trader Mark
- The Electric Car Market: Wise Energy Use Stocks by Tom Konrad
- Investing in the Power of the Sea
- ETF Daily -SampleSeeking Alpha - ETF DailySector ETFs
- Too Early To Buy Homebuilders ETF by Larry MacDonald
- Utilities Beginning to Generate Interest for Longs by Joe Kunkle
- Two Global Infrastructure Investment Opportunities in ETFs by Investment U
New ETFs- First Trust Launches Infrastructure ETF with Global Reach by Index Universe
- Overview and Analysis of the Global Generic Drug Industry by Mike Havrilla
Emerging Market ETFs- Brazil Is the Best of BRIC by Carl T. Delfeld
- Playing the Market in Difficult Times by Jason Hamlin
- The Daily Dispatch -SampleSeeking Alpha - Daily DispatchWall Street Breakfast
- Wall Street Breakfast: Must-Know News by SA Editor Rachael Granby
US Market- An Outcry from Emerging and Developed Markets Alike by Jonathan O'Shaughnessy
- Wall Street Breakfast: Must-Know News by SA Editor Rachael Granby
Housing & Real Estate- Too Early To Buy Homebuilders ETF by Larry MacDonald
- Another 'Root Cause' That Isn't: Tumbling Home Prices by Tim Iacono
Transcripts- TrueBlue, Inc. Q3 2008 Earnings Call Transcript
- Polycom, Inc. Q3 2008 Earnings Call Transcript
ETF- Too Early To Buy Homebuilders ETF by Larry MacDonald
- About Seeking Alpha
- About Us
- Contact Us
- What's New
- Readers Feedback
- Advertise With Us
- Contributors
- Contribute an Article
- Feature Your Book
- Our Contributors
- Anonymous Contributions
- Dispute an Article?
- Legal
- Terms of Use
- Privacy
- Copyright
Latest Comments80 Comments
OPEC's Move to Devalue the Euro
OPEC will help America or US$? Get real. Do you expect much help from Iran and Venezuela?
Will Icahn Bail from His Yahoo Position?
Yes, he tried to run business: TWA. It went into a bankruptcy and out of business in a hurry.
So, if Carl gets his wish taking over Yahoo with his own money, he will lose his ass. There are not too many buyers for Yahoo especially with cash to pay.
PS
In the present financial environment, there are not to many banks with a desire to lend him money for this kind of entertainment.
Is Lilly and Amylin's Byetta Better?
During the last 4 years company insiders received and cashed out huge amounts of granted options in spite of terrible sale or stock price performance.
AMLN has total disregard for it shareholders.
AMLN was burning money having huge expenses but their clinical trials looked more like Mickey Mouse trials with too few patients to be conclusive.
The last trial for LAR Byetta was a comparative trial with so few patients than it is impossible to make any definite conclusion regarding either Byetta or LAR Byetta efficacy.
Bernanke Seems Willing To Allow More Downturn Than Greenspan
Stalin and Mao have killed many times more people than A. Hitler.
Nazi did not invent extermination gas-chambers and concentration camps. Extermination gas-chambers were invented and widely used by Bolsheviks in 1920s. The first concentration camps were invented and used by British.
The real initiator of the WWII was not Hitler. The main driver forces behind the war were J. Stalin and FDR.
Yes, Nazi committed lots of crimes but during their colonial times British commited much more crimes specifically in India.
Finally, Americans use A-bombs to kill endless civilians in Japan. The plan B, if America did not have A-bombs, was to gas millions of Japanese.
So much about bad Nazi and good American.
Investors at Risk of Losing Everything
McCain is just outright dangerous: a warmongering scoundrel with no respect for the Constitution.
Is Oil a Bubble? Part 3
It is just stupid to blame the Congress for high gas prices and dependence on foreign and unfriendly energy suppliers.
The US Congress just reflects the overall bankruptcy of the entire US way of life. Its moral, intellectual and economic values are in disarray and in crises. The degradation started at Lyndon Johnson "Great Society", and started to accelerate during both Clinton and G. W. Bush administrations.
The American consumer-consumption driven economic model is nothing more or less as a parasitic way of life using somebody else money without any intention to pay it back.
For the last 40+ years, America lived well above its means. It is a very long time; it could not last forever [similar to the Soviet Communist model], and eventually the time is up.
Just to blame specific individuals in the Congress and in the Administration is stupid. These scoundrels were elected by American people.
Now, America is about to start a transition to its new way of life. It will not be a painless transition. Just look at Russia. Ten years ago, Russia was in a terrible crisis. Now, it is one of the most dynamic and growing prosperity society.
America will survive. It will take some time. America will be a very much different country.
Yahoo Denies Poison Pill: Icahn 'Manipulates the Facts'
His damage is enormous. His objectives are to make a fast buck for himself regardless for damage he makes.
Just look at Biogen. It is one of the best biotech company developing highly successful drugs that save tens of thousands of lives. However, now, Biogen management must spend a lot of time and energy to defend itself from Icahn desire to ruin the company.
It appears that this corporate raider is responsible for more deaths and suffering than Osama Ben Laden.
Bristol-Myers, ImClone, Genentech Release Promising Data at ASCO
"Also we must not forget that when Mike Huckman asked at the ASCO the doctors if they would prescribe Erbitux to their patients the vast majority said yes. And the one that wasn't sure was from Canada."
It is important to mention that Erbitux is not available in Canada. Bristol (who does Erbitux marketing in North America) is still negotiating with Canadian government Erbitux's price sold there.
Bristol-Myers, ImClone, Genentech Release Promising Data at ASCO
Yes indeed, in general ITT [intend to treat] patient population adding Erbitux to chemotherapy extended the overall survival rate to 11.3 months from the 10.1 months for chemotherapy alone.
But this is not the entire story. Flex trial patients population included substantially broader spectrum of patients than the Avastin trial Jason Napodano has mentioned.
So let compare apples with apples:
- the Avastin trial #E4599 was conducted exclusively in Adeno-ca lung cancer patients. Addition of Avastin to chemotherapy improved median survival rates from 10.3 months to 12.3 months. Furthermore, cancer patients in Avastin #E4599 trials were ECOG 0-1 [relatively "healthy" patients] compare with more sick FLEX patients with ECOG 0-2.
In these more sick Adeno-ca lung cancer patients, addition of Erbitux to chemotherapy improved median survival from 10.2 months to 12 months. FLEX Erbitux median survival benefits to more difficult to treat lung cancer patients were practically identical to Avastin.
- But it is not all. FLEX ITT patient population also included SCC- lung cancer patients. These cancer patients can NOT be treated by Avastin due to severe life-threatening side-effects. In this lung cancer population, addition of Erbitux to chemotherapy improved median survival from 8.9 months to 10.2 months.
- It is true, Erbitux did not work on Asian patients. Addition of Erbitux to chemotherapy reduced these patients median survival. Erbutux should not be used in Asian lung-cancer patients.
- Avastin and Erbitux belong to two different classes of drugs. Erbitux is a EGFr-drug. It offers substantial clinical benefits to only a select group of patients and no benefits to the rest. By identifying Erbitux-responding patients [like it is done using biomarkers in colorectal cancers], survival benefits offered by Erbitux are much superior to Avastin benefits.
- Finally, the latest Avastin clinical trials in lung cancer failed to show survival benefits. Consequently, effictiviness of Avastin in lung-cancer became an issue.
ASCO: Whose Presentations Look the Most Promising?
Kras data are extremely important since Kras-status will identify cancer patients who will greatly benefit from using EGFr drugs specifically Erbitux from ImClone.
Erbitux is a very expensive drug but it offers to select head & neck, lung and colorectal cancer patients substantial survival benefits, improved quality of life, and for some patients cancer-free survival and even a cure.
Knowing the Kras-status, physicians will be very much eager offering Erbitux to patients who will DEFINITELY benefit from it. This will establish Erbitux as a standard of care for these patients.
This will make Erbitux a mega-blockbuster. Note that Erbitux's worldwide sale is already over $1.5B.
Icahn Boosts Stake in Amylin to 6.5%, Seeks Additional Talks
AMLN's situation is very complex:
- its management is very greedy and incompetent
- Symlin is a niche drug as of now with very limited sale potential
- Byetta is their major product responsible for 90% of AMLN sale and it has a strong competition from Merck's Januvia. Byetta LAR is the most important AMLN program since Byetta competition is coming from all sides.
Finally, Byetta and Byetta LAR are partnered with LLY. This agreement is very complex and not in AMLN favor. In a case of AMLN is taken over by other company, LLY has rights to demand transferring Byetta franchise to them.
Based on my experience (IMCL investor from 1998)with ImClone where Carl is the BOD Chairman, Carl is a greenmailer and knows nothing about complexity of biotech business. If not for IMCL's partner Merck KgaA who does all Erbitux R&D, IMCL would be long ago out of business.
Crude Oil Prices: Bears Will Soon Win Out
Yes, it is true. But as long as
- US foreign and domestic deficits keep growing
- US Treasury and Fed are printing US$ as if there is no tomorrow
There is no way US$ will stop falling in a long-run.
Oil Is Up Due to Fundamentals, Not Speculation
Just in the last 6 months, the Fed has printed over 800 millions US peso [sorry US$$$].
Commodities: Oil Correction Likely; No Gold Bubble
How long will the rest of world sell to America goods for US peso?
The Oil Shortage, and Other Fairy Tales
In the last 3 years, US$ lost 50% against euro. Consequently, if commodities did not change in euro then their prices had to double in US$.
However, EU central banks are too printing a lot of new euros. Consequently, commodities had to go up in euro too. There are no ways to "print" commodities.
The author unfortunately does not mentioned that US government and US Congress totally irresponsible policies are the real reasons for the disastrous state of US economy and runaway commodities prices.